Phenotypic screen for oxygen consumption rate identifies an anti-cancer naphthoquinone that induces mitochondrial oxidative stress
- Author(s)
- Byrne, FL; Olzomer, EM; Marriott, GR; Quek, LE; Katen, A; Su, J; Nelson, ME; Hart-Smith, G; Larance, M; Sebesfi, VF; Cuff, J; Martyn, GE; Childress, E; Alexopoulos, SJ; Poon, IK; Faux, MC; Burgess, AW; REID, G; McCarroll, JA; Santos, WL; Quinlan, KG; Turner, N; Fazakerley, DJ; Kumar, N; Hoehn, KL;
- Journal Title
- Redox Biology
- Publication Type
- Journal Article
- Abstract
- A hallmark of cancer cells is their ability to reprogram nutrient metabolism. Thus, disruption to this phenotype is a potential avenue for anti-cancer therapy. Herein we used a phenotypic chemical library screening approach to identify molecules that disrupted nutrient metabolism (by increasing cellular oxygen consumption rate) and were toxic to cancer cells. From this screen we discovered a 1,4-Naphthoquinone (referred to as BH10) that is toxic to a broad range of cancer cell types. BH10 has improved cancer-selective toxicity compared to doxorubicin, 17-AAG, vitamin K3, and other known anti-cancer quinones. BH10 increases glucose oxidation via both mitochondrial and pentose phosphate pathways, decreases glycolysis, lowers GSH:GSSG and NAPDH/NAPD(+) ratios exclusively in cancer cells, and induces necrosis. BH10 targets mitochondrial redox defence as evidenced by increased mitochondrial peroxiredoxin 3 oxidation and decreased mitochondrial aconitase activity, without changes in markers of cytosolic or nuclear damage. Over-expression of mitochondria-targeted catalase protects cells from BH10-mediated toxicity, while the thioredoxin reductase inhibitor auranofin synergistically enhances BH10-induced peroxiredoxin 3 oxidation and cytotoxicity. Overall, BH10 represents a 1,4-Naphthoquinone with an improved cancer-selective cytotoxicity profile via its mitochondrial specificity.
- Research Division(s)
- Personalised Oncology
- PubMed ID
- 31743887
- Publisher's Version
- https://doi.org/10.1016/j.redox.2019.101374
- Open Access at Publisher's Site
https://doi.org/10.1016/j.redox.2019.101374- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2019-11-21 09:29:38
Last Modified: 2019-11-21 09:45:14